GlassScriptPhysician profile
Donetta R Wallace
NPI 1417958828
$9,191.63
in general payments reported to CMS, 2019-2025
40 companies · $749 in 2025
The $749 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,994 · 2022: $2,466 · 2023: $2,355 · 2024: $1,628 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,731.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,631.42 | 2021-2025 | |
| Novo Nordisk INC | $1,264.11 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $1,031.66 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Amgen INC. | $553.57 | 2021-2024 | Otezla, Repatha, Evenity |
| Pfizer INC. | $508.34 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $436.94 | 2021-2024 | Trintellix |
| Astrazeneca Pharmaceuticals LP | $365.35 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Janssen Pharmaceuticals, INC | $360.21 | 2021-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $265.65 | 2021-2024 | |
| Exact Sciences Corporation | $257.93 | 2023-2025 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $250.71 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $245.14 | 2021-2024 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Biohaven Pharmaceutical Holding Company LTD. | $214.13 | 2022 | |
| Sanofi-Aventis U.S. LLC | $197.61 | 2021-2023 | |
| Lilly USA, LLC | $189.58 | 2021-2024 | Mounjaro, Jardiance, Zepbound |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donetta Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.